| Facing regulatory challenges of on-line hemodiafiltration. | |
| | |
MedLine Citation:
|
PMID: 22188690 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
On-line hemodiafiltration (on-line HDF) is the result of a vision that triggered multifarious changes in very different areas. Driven by the idea to offer better medical treatment for renal patients, technological innovations were developed and established that also constituted new challenges in the field of regulatory affairs. The existing regulations predominantly addressed the quality and safety of those products needed to perform dialysis treatment which were supplied by industrial manufacturers. However, the complexity of treatment system required for the provision of on-line fluids demanded a holistic approach encompassing all components involved. Hence, focus was placed not only on single products, but much more on their interfacing, and the clinical infrastructure, in particular, had to undergo substantial changes. The overall understanding of the interaction between such factors, quite different in their nature, was crucial to overcome the arising regulatory obstacles. This essay describes the evolution of the on-line HDF procedure from the regulatory point of view. A simplified diagram demonstrates the path taken from the former regulatory understanding to the realization of necessary changes. That achievement was only possible through 'management of preview' and consequent promotion of technical and medical innovations as well as regulatory re-evaluations. |
| | |
Authors:
|
Wolfgang Kümmerle |
Publication Detail:
|
Type: Journal Article Date: 2011-12-15 |
Journal Detail:
|
Title: Contributions to nephrology Volume: 175 ISSN: 1662-2782 ISO Abbreviation: Contrib Nephrol Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-12-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7513582 Medline TA: Contrib Nephrol Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 74-80 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 S. Karger AG, Basel. |
Affiliation:
|
Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Regulatory challenges of on-line hemodiafiltration.
Next Document: The membrane permeability outcome study.